You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › July › 23
Eli
6 days ago
There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of its obesity portfolio.
page 1 of 1